Skip to content

PolitiKit

Joan Eliasek's lobbying: the registrations they file and every meeting they've reported since November 2021.

← Lobbying

Registrant (responsible officer)

Joan Eliasek

President

For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.

Meetings this Parliament
9
Since Nov 2021
29
Active registrations
0

Reported meetings

  • McKesson Canada
    Approaches towards National Pharmacare policy Read more

    Health Canada, with respect to the role of wholesalers in the management of drug shortages

    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Guillaume Couillard · Director General, Patented Medicine Prices Review Board (PMPRB)
    Offer recommendations on the Patented Medicines Pricing Review Board excessive pricing policy guidelines and implementation approaches to support drug supply stability and system sustainability Read more

    Official report

  • McKesson Canada
    • Neeraj Bhalla · Director Stakeholder Relations, Global Affairs Canada (GAC)
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Galen Richardson · Senior Policy Advisor Stakeholder Relations, Privy Council Office (PCO)
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Anie Perrault · Acting Chairperson, Patented Medicine Prices Review Board (PMPRB)
    Offer recommendations on the Patented Medicines Pricing Review Board excessive pricing policy guidelines and implementation approaches to support drug supply stability and system sustainability Read more

    Official report

  • McKesson Canada
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Jibril Hussein · Intern, Innovation, Science and Economic Development Canada (ISED)
    • Sandenga Yeba · Senior Policy Advisor to the Minister, Health Canada (HC)
    • Bryn Savage · Policy Advisor, Health Canada (HC)
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Sean Burgess · Communications Consultant, Health Canada (HC)
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Eshan Naik · Dir Policy & Health Policy, Health Canada (HC)
    Discuss policy measures to protect Canada's drug supply, distribution, and pharmacy systems against the impact of US tariffs

    Official report

  • McKesson Canada
    • Bryce McRae · Manager of Stakeholder Relations, House of Commons
    Health Canada, with respect to the role of wholesalers in the management of drug shortages

    Official report

  • McKesson Canada
    • Pierre Poilievre · Member of Parliament
    • Matthew Antonitti · Chief of Operations, House of Commons
    Health Canada, with respect to the role of wholesalers in the management of drug shortages

    Official report

  • McKesson Canada
    Health Canada, with respect to the role of wholesalers in the management of drug shortages Read more

    Approaches towards National Pharmacare policy

    Official report

  • McKesson Canada
    • Ian Foucher · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)

    Health

    Official report

  • McKesson Canada
    • Cyndi Jenkins · Chief of Staff, Health Canada (HC)

    Health

    Official report

  • McKesson Canada
    • Dani Saad · Senior Policy Advisor, Prime Minister's Office (PMO)

    Health

    Official report

  • McKesson Canada
    • Marc Holland · Minister, Health Canada (HC)

    Health

    Official report

  • McKesson Canada

    Health

    Official report

  • McKesson Canada
    • Jean-Sebastian Bock · Deputy Chief of Staff and Director of Policy, Health Canada (HC)

    Health

    Official report

  • McKesson Canada

    Health

    Official report

  • McKesson Canada

    Health

    Official report

  • McKesson Canada
    • Laurel Lennox · Advisor Issues Management & Communications, Innovation, Science and Economic Development Canada (ISED)

    Health

    Official report

  • McKesson Canada
    • Laurence Lefevre · QC Desk Policy Advisor, Health Canada (HC)

    Health

    Official report

  • McKesson Canada
    • Philip Proulx · ED and Quebect Desk Director at the Prime Minister's Office, Health Canada (HC)
    • John Ophelia · Sr Policy Advisory, Office of the Health Minister, Health Canada (HC)

    Health

    Official report

  • McKesson Canada
    • Jean-Sebastien Bock · Deputy Chief of Staff and Director of Policy, Health Canada (HC)
    • Jade Maillette · Director of Parliamentary Affairs, Health Canada (HC)

    Health

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.